Bernstein Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $51

Moomoo NewsJan 7 04:32 ET · Ratings

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic

BenzingaJan 3 13:08 ET

Insider Trades: Walmart, Teva Among Notable Names This Week

Seeking AlphaDec 28, 2024 11:03 ET

Are Investors Undervaluing Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) By 31%?

Simply Wall StDec 27, 2024 07:29 ET

Insider Purchase: Director at $IONS (IONS) Buys 2,500 Shares

Quiver QuantitativeDec 26, 2024 17:01 ET

Analysts Offer Insights on Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (SXTP), Ionis Pharmaceuticals (IONS) and Zura Bio (ZURA)

TipRanksDec 25, 2024 06:51 ET · Ratings